The Thread Formerly Known as No Rest For The Wicked Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tim Luke who wrote (2866)	12/10/1998 10:02:00 AM
From: Captain Ed	Read Replies (1) of 90042

GERN .. Good news in today's Nature Magazine...may also help ASTM and other similar stocks. In today's issue of Nature Magazine (December 10, 1998) volume 396, pp. 506-508, there is a very interesting and significant news story. In the article, it states that the Senate Appropriations committee for Labor, Health, and Education, which is chaired by Arlen Specter, is LIKELY TO REVISE THE CURRENT BAN on stem cell research, at least as performed by GERN. This is because the work performed by GERN was on stem cells isolated from fetal tissue rather than embryos... This is a quick synopsis of the article. It is copyrighted, so I cannot reproduce it in full. I got it from the nature web site nature.com. If this change occurs, it will open the doors to federal funding for GERN (and probably others, but GERN is specifically mentioned in the article.) Ed I also saw a rumor on the Yahoo threads that there is an article in tomorrow's Science Magazine that will describe highly successful cloning of cattle, which may give a further boost to these companies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next